LIBER-CEL Trademark

Trademark Overview


On Tuesday, January 25, 2022, a trademark application was filed for LIBER-CEL with the United States Patent and Trademark Office. The USPTO has given the LIBER-CEL trademark a serial number of 97238044. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 11, 2024. This trademark is owned by Atara Biotherapeutics, Inc.. The LIBER-CEL trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders
liber-cel

General Information


Serial Number97238044
Word MarkLIBER-CEL
Filing DateTuesday, January 25, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2022

Trademark Statements


Goods and Servicespharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, January 31, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAtara Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 91320

Party NameAtara Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Monday, March 11, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 11, 2024ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 1, 2023SOU EXTENSION 1 GRANTED
Tuesday, August 1, 2023SOU EXTENSION 1 FILED
Tuesday, August 1, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 24, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 24, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 3, 2022ASSIGNED TO EXAMINER
Monday, January 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 28, 2022NEW APPLICATION ENTERED